chevron_leftBack
As of 14 June 2026, R&G PharmaStudies Co., Ltd. has a market cap of $899.14M USD, ranking #11320 globally and #3262 in China.
It ranks #1016 in the Healthcare sector, and #191 in the Biotechnology industry.
Key Stats
Market Cap
$899.14MUSD
6.09B CNY
Enterprise Value
$653.68MUSD
4.42B CNY
Revenue (TTM)
$132.27MUSD
896.26M CNY
EBITDA (TTM)
$18.82MUSD
127.36M CNY
Net Income (TTM)
$19.72MUSD
133.65M CNY
EBITDA Margin
14%
Profit Margin
15%
PE Ratio
45.3
Forward PE
36.7
PS Ratio
6.8
PB Ratio
3.0
EV/EBITDA
31.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Jie Wu
open_in_new
Employees
2,645
Founded
2008
Website
rg-pharma.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -3.6% | -7.6% | 2.2% | -8.9% | 23% | 43% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
301333
诺思格(北京)医药科技股份有限公司 Class A
ISIN: CNE100005K44
Shares Out.:
Shares Outstanding:
56.722M1
Shares Float:
17.858M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
63.47 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About R&G PharmaStudies Co., Ltd.
R&G PharmaStudies Co., Ltd. operates as a clinical trial outsourcing service provider in China and internationally. It offers drug clinical research and development integrated services. The company’s services include clinical trial operation, clinical trial site management, biological sample testing, data management and statistical analysis, clinical trial consulting, and clinical pharmacology services. It serves pharmaceutical and medical device companies, and scientific research institutions. The company was founded in 2008 and is headquartered in Beijing, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SHEK: 2269
|
$17.44B
2K%
136.71B HKD
|
25.3
|
|
SHEK: 1093
|
$12.2B
1K%
95.58B HKD
|
22.1
|
|
SHE: 002422
|
$8.0B
790%
54.23B CNY
|
34.4
|
|
|
$7.33B
716%
49.69B CNY
|
-
|
||
SHEK: 1530
|
$7.08B
688%
55.5B HKD
|
5.8
|
|
SHE: 300347
|
$6.72B
647%
45.52B CNY
|
61.6
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
20K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
18K%
|
19.0
|
|
EBR: ARGX
|
$47.84B
5K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.84B
5K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$42.36B
5K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$42.3B
5K%
33.71B CHF
|
37.2
|
chevron_leftBack